Compare YUM & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YUM | MDLN |
|---|---|---|
| Founded | 1997 | 1966 |
| Country | United States | United States |
| Employees | N/A | 45000 |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.7B | 37.4B |
| IPO Year | 1997 | N/A |
| Metric | YUM | MDLN |
|---|---|---|
| Price | $151.37 | $38.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 23 |
| Target Price | ★ $168.87 | $50.48 |
| AVG Volume (30 Days) | 1.5M | ★ 6.1M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.88% | N/A |
| EPS Growth | ★ 6.32 | N/A |
| EPS | ★ 1.55 | N/A |
| Revenue | ★ $8,214,000,000.00 | N/A |
| Revenue This Year | $12.11 | $10.88 |
| Revenue Next Year | $5.84 | $7.69 |
| P/E Ratio | ★ $97.37 | $658.75 |
| Revenue Growth | ★ 8.81 | N/A |
| 52 Week Low | $137.33 | $37.65 |
| 52 Week High | $169.39 | $50.88 |
| Indicator | YUM | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 41.68 | 28.99 |
| Support Level | $146.95 | N/A |
| Resistance Level | $152.94 | $44.89 |
| Average True Range (ATR) | 3.58 | 1.67 |
| MACD | -0.63 | -0.68 |
| Stochastic Oscillator | 14.06 | 5.17 |
As of the end of 2025, Yum Brands generated over $68 billion in systemwide sales from more than 63,000 restaurants across 155 markets, making it the world's second-largest restaurant firm by dollar sales. Its portfolio includes KFC (33,897 stores), Pizza Hut (19,974), Taco Bell (9,030), and Habit Burger (384), with 72% of locations in international markets. As 97% of its portfolio is franchised, Yum's business model is tilted toward recurring franchise royalties and marketing contributions (64% of revenue), with the balance derived from sales at company-owned locations. The company traces its roots to a 1997 spinoff of PepsiCo's restaurant assets.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.